<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="97403">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01841957</url>
  </required_header>
  <id_info>
    <org_study_id>2</org_study_id>
    <nct_id>NCT01841957</nct_id>
  </id_info>
  <brief_title>Immediate Simultaneous Bilateral Cataract Surgery</brief_title>
  <acronym>ISBCS</acronym>
  <official_title>Immediate Simultaneous Bilateral Cataract Surgery: A Prospective, Case-controlled Clinical Trial in the United States</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sloan W. Rush, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Panhandle Eye Group, LLP</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and efficacy of treating visually significant bilateral cataract with
      the newer technique of Immediate Simultaneous Bilateral Cataract Surgery (ISBCS) versus the
      conventional technique of Delayed Sequential Bilateral Cataract Surgery (DSBCS) in a select
      patient population.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>3 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Best uncorrected and best spectacle corrected post-operative visual acuity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recovery time and number of post-operative visits</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Bilateral Cataract</condition>
  <arm_group>
    <arm_group_label>ISBCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Immediate Simultaneous Bilateral Cataract Surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DSBCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Delayed Sequential Bilateral Cataract Surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ISBCS</intervention_name>
    <description>same-day cataract surgery</description>
    <arm_group_label>ISBCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>DSBCS</intervention_name>
    <description>bilateral surgery delayed by 1-3 weeks amongst eyes</description>
    <arm_group_label>DSBCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 30-100

          -  Candidate for topical anesthesia

          -  Signed the informed consents

        Exclusion Criteria:

          -  Allergies to medications used in study

          -  Cannot have topical anesthesia

          -  Unwilling to participate in research trial

          -  Have any other significant ocular comorbidities

          -  Have known systemic immuno-compromised state
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sloan Rush, MD</last_name>
    <phone>806-353-0125</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sunday Fowler</last_name>
    <phone>806-353-0125</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Panhandle Eye Group</name>
      <address>
        <city>Amarillo</city>
        <state>Texas</state>
        <zip>79106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunday Fowler</last_name>
      <phone>806-353-0125</phone>
    </contact>
    <investigator>
      <last_name>Sloan Rush</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 24, 2013</lastchanged_date>
  <firstreceived_date>April 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Panhandle Eye Group, LLP</investigator_affiliation>
    <investigator_full_name>Sloan W. Rush, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Bilateral Cataract</keyword>
  <keyword>Simultaneous Cataract Surgery</keyword>
  <keyword>ISBCS</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
